HIF-1 activation attenuates postischemic myocardial injury: role for heme oxygenase-1 in modulating microvascular chemokine generation.

The CXC chemokine IL-8, which promotes adhesion, activation, and transmigration of polymorphonuclear neutrophils (PMN), has been associated with production of tissue injury in reperfused myocardium. Hypoxia-inducible factor-1 (HIF-1) is a heterodimeric peptide that is a key regulator of genes such as heme oxygenase (HO)-1 expressed under hypoxic conditions. We hypothesized that HO-1 plays an important role in regulating proinflammatory mediator production under conditions of ischemia-reperfusion. HIF-1 was activated in the human microvascular endothelial cell line (HMEC-1) with the prolyl hydroxylase inhibitor dimethyloxalylglycine (DMOG). DMOG significantly attenuated cytokine-induced IL-8 promoter activity and protein secretion and cytokine-induced PMN migration across human microvascular endothelial cell line HMEC-1 monolayers. In vivo studies in a rabbit model of myocardial ischemia-reperfusion showed that rabbits pretreated with a 20 mg/kg DMOG infusion (n = 6) 24 h before study exhibited a 21.58 +/- 1.76% infarct size compared with 35.25 +/- 2.06% in saline-treated ischemia-reperfusion animals (n = 6, change in reduction = 39%; P < 0.001). In DMOG-pretreated (20 mg/kg) animals, plasma IL-8 levels at 3 h after onset of reperfusion were 405 +/- 40 pg/ml vs. 790 +/- 40 pg/ml in saline-treated ischemia-reperfusion animals (P < 0.001). DMOG pretreatment reduced myocardial myeloperoxidase activity, expressed as number of PMN per gram of myocardium, to 1.43 +/- 0.59 vs. 4.86 +/- 1.1 (P = 0.012) in saline-treated ischemia-reperfused hearts. Both in vitro and in vivo DMOG-attenuated IL-8 production was associated with robust HO-1 expression. Thus our data show that HIF-1 activation induces substantial HO-1 expression that is associated with attenuated proinflammatory chemokine production by microvascular endothelium in vitro and in vivo.

[1]  R. Bolli,et al.  Administration of a CO-releasing molecule induces late preconditioning against myocardial infarction. , 2005, Journal of molecular and cellular cardiology.

[2]  R. Bolli,et al.  Administration of a CO-releasing molecule at the time of reperfusion reduces infarct size in vivo. , 2004, American journal of physiology. Heart and circulatory physiology.

[3]  S. Moncada,et al.  Antiinflammatory activity of soluble guanylate cyclase: cGMP-dependent down-regulation of P-selectin expression and leukocyte recruitment. , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[4]  D. Yellon,et al.  Characterisation of the infarct-limiting effect of delayed preconditioning: timecourse and dose-dependency studies in rabbit myocardium , 1997, Basic Research in Cardiology.

[5]  A. Choi,et al.  MKK3 mitogen-activated protein kinase pathway mediates carbon monoxide-induced protection against oxidant-induced lung injury. , 2003, The American journal of pathology.

[6]  F. Coulet,et al.  Identification of Hypoxia-response Element in the Human Endothelial Nitric-oxide Synthase Gene Promoter* , 2003, Journal of Biological Chemistry.

[7]  J. Gu,et al.  Plasma levels of IL-8 predict early complications in patients with coronary heart disease after percutaneous coronary intervention. , 2003, Japanese Heart Journal.

[8]  F. Salloum,et al.  Sildenafil Induces Delayed Preconditioning Through Inducible Nitric Oxide Synthase–Dependent Pathway in Mouse Heart , 2003, Circulation research.

[9]  A. Fowler,et al.  Atypical mechanism of NF-kappaB activation during reoxygenation stress in microvascular endothelium: a role for tyrosine kinases. , 2002, Free radical biology & medicine.

[10]  F. Salloum,et al.  Sildenafil (Viagra) induces powerful cardioprotective effect via opening of mitochondrial K(ATP) channels in rabbits. , 2002, American journal of physiology. Heart and circulatory physiology.

[11]  Shobha Ghosh,et al.  Reoxygenating microvascular endothelium exhibits temporal dissociation of NF-kappaB and AP-1 activation. , 2002, Free radical biology & medicine.

[12]  M. I. Tejero-Taldo,et al.  Alpha-adrenergic receptor stimulation produces late preconditioning through inducible nitric oxide synthase in mouse heart. , 2002, Journal of molecular and cellular cardiology.

[13]  A. Szuba,et al.  The role of chemokines in human cardiovascular pathology: enhanced biological insights. , 2002, Atherosclerosis.

[14]  K. Valerie,et al.  p38 Triggers Late Preconditioning Elicited by Anisomycin in Heart: Involvement of NF-&kgr;B and iNOS , 2001, Circulation research.

[15]  J. Ingwall,et al.  Cardiac-Specific Expression of Heme Oxygenase-1 Protects Against Ischemia and Reperfusion Injury in Transgenic Mice , 2001, Circulation research.

[16]  P. Bhargava,et al.  Chemical preconditioning with 3-nitropropionic acid in hearts: role of mitochondrial K(ATP) channel. , 2001, American journal of physiology. Heart and circulatory physiology.

[17]  J. Levasseur,et al.  Inducible nitric oxide synthase mediates delayed myocardial protection induced by activation of adenosine A(1) receptors: evidence from gene-knockout mice. , 2000, Circulation.

[18]  G. Semenza,et al.  HIF-1 and human disease: one highly involved factor. , 2000, Genes & development.

[19]  G. Semenza,et al.  Hypoxia-inducible factor 1alpha protein expression is controlled by oxygen-regulated ubiquitination that is disrupted by deletions and missense mutations. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[20]  S. Viselli,et al.  Staining and quantification of proteins transferred to polyvinylidene fluoride membranes. , 2000, Analytical biochemistry.

[21]  F. Salloum,et al.  Glycolipid RC-552 induces delayed preconditioning-like effect via iNOS-dependent pathway in mice. , 1999, American journal of physiology. Heart and circulatory physiology.

[22]  S. Ghosh,et al.  Nitric oxide regulates interleukin-8 gene expression in activated endothelium by inhibiting NF-kappaB binding to DNA: effects on endothelial function. , 1999, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[23]  P. Poindron,et al.  Determination of heme oxygenase activity in murine macrophages for studying oxidative stress inhibitors. , 1998, Analytical biochemistry.

[24]  K. Matsushima,et al.  Inhibition of neutrophil-mediated acute inflammatory injury by an antibody against interleukin-8 (IL-8) , 1998, Inflammation Research.

[25]  L. Huang,et al.  Regulation of hypoxia-inducible factor 1α is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway , 1998 .

[26]  E. Chi,et al.  Inhibition of interleukin-8 blocks myocardial ischemia-reperfusion injury. , 1998, The Journal of thoracic and cardiovascular surgery.

[27]  Yongge Liu,et al.  Mitochondrial ATP-dependent potassium channels: novel effectors of cardioprotection? , 1998, Circulation.

[28]  A. Hsu,et al.  Ischemic Preconditioning in the Intact Rat Heart Is Mediated by δ1- But Not μ- or κ-Opioid Receptors , 1998 .

[29]  G. Semenza,et al.  Transactivation and Inhibitory Domains of Hypoxia-inducible Factor 1α , 1997, The Journal of Biological Chemistry.

[30]  G. Melillo,et al.  Functional Requirement of the Hypoxia-responsive Element in the Activation of the Inducible Nitric Oxide Synthase Promoter by the Iron Chelator Desferrioxamine* , 1997, The Journal of Biological Chemistry.

[31]  R. Levy,et al.  Neutrophil superoxide release and interleukin 8 in acute myocardial infarction: distinction between complicated and uncomplicated states , 1997, European journal of clinical investigation.

[32]  M. Chiariello,et al.  Oxygen radicals can induce preconditioning in rabbit hearts. , 1997, Circulation research.

[33]  G. Semenza,et al.  Hypoxia-inducible Factor-1 Mediates Transcriptional Activation of the Heme Oxygenase-1 Gene in Response to Hypoxia* , 1997, The Journal of Biological Chemistry.

[34]  G. Semenza,et al.  Hypoxia Response Elements in the Aldolase A, Enolase 1, and Lactate Dehydrogenase A Gene Promoters Contain Essential Binding Sites for Hypoxia-inducible Factor 1* , 1996, The Journal of Biological Chemistry.

[35]  D. Livingston,et al.  Activation of Hypoxia-inducible Transcription Factor Depends Primarily upon Redox-sensitive Stabilization of Its α Subunit* , 1996, The Journal of Biological Chemistry.

[36]  G. Semenza,et al.  Dimerization, DNA Binding, and Transactivation Properties of Hypoxia-inducible Factor 1* , 1996, The Journal of Biological Chemistry.

[37]  AlbertSchömig,et al.  Cardiac Release of Cytokines and Inflammatory Responses in Acute Myocardial Infarction , 1995 .

[38]  G. Semenza,et al.  Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[39]  G. Semenza,et al.  Purification and Characterization of Hypoxia-inducible Factor 1 (*) , 1995, The Journal of Biological Chemistry.

[40]  K. Matsushima,et al.  Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8 , 1993, Nature.

[41]  C. Cairns,et al.  Preconditioning against myocardial dysfunction after ischemia and reperfusion by an alpha 1-adrenergic mechanism. , 1993, Circulation research.

[42]  J. Downey,et al.  Preconditioning Causes Improved Wall Motion as Well as Smaller Infarcts After Transient Coronary Occlusion in Rabbits , 1991, Circulation.

[43]  J. Downey,et al.  Protection Against Infarction Afforded by Preconditioning is Mediated by A1 Adenosine Receptors in Rabbit Heart , 1991, Circulation.